If you want to be in the know about what’s going on at our organization, you’ve come to the right place.
Be sure to check back regularly to get our latest news updates.
"Administration of exogenous 9-cis retinal, an analog of the naturally occurring 11-cis retinal, improved ERG amplitudes in these mutant mice, suggesting a basis for a clinical trial of exogenous FDA approved retinoids to preserve vision in USH1F patients."
Read our newsletter to learn about our latest updates, including exciting news about our conference and RUSH1F natural history study.
COLUMBIA, Maryland – April 29, 2021 – Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, is partnering with the Usher 1F Collaborative, a family-founded nonprofit driving research for Usher syndrome type 1F (USH1F), to launch a natural history study, the Rate of Progression in PCDH15-Related Retinal Degeneration in Usher Syndrome 1F (RUSH1F). The project will help identify outcome measures for future clinical trials of potential USH1F therapies.
Eight-year-old Zachary Root, with a little help from his parents and his dad’s college friends from the University of Arizona, launched the Usher 1F Cereal Challenge on February 13th. While we had high hopes for this virtual fundraising campaign, we never could have anticipated the response and outpouring of support. Thank you so much to everyone who has joined us!
We wanted to update you on the amazing progress your support has made possible. With over 1000 videos posted on social media, not just across the U.S. but also around the world in Canada, Australia, Switzerland, and the U.K., to date the Cereal Challenge, #Usher1FCerealChallenge, has brought in $150,000 for much needed Usher 1F research.
Our Cereal Challenge is still going on. If you haven’t joined us yet, check out #Usher1FCerealChallenge on Facebook and Instagram, and join the Challenge to help us reach our $250,000 goal, which will fund a year of research at two of our research labs!
This is our Usher 1F gene - "With support from our generous donors, Dr. Tropepe will be studying how mutations in the Pcdh15b gene – a gene that affects approximately 20% of patients with USH1- affects photoreceptor structure and function in zebrafish."
Please enjoy our Fall/Winter 2020 newsletter.
Watch David Corey, PhD, Harvard Medical School, describe his promising gene therapy research for Usher 1F.
Read our latest news and updates
Update on Usher 1F research during this difficult time
The laboratory of CSB Chair Vincent Tropepe has received funding from Fighting Blindness Canada to conduct research using zebrafish to study Usher syndrome type 1F. Loss of vision in Usher 1F is the result of retinal degeneration, but the mechanism through which degeneration happens in unknown.
Clues to the way retinal degeneration happens in Usher 1F can be found in the zebrafish model organism. The gene that is altered in those with Usher 1F is also present in zebrafish, and mutations in zebrafish that mimic the Usher-linked changes in this ‘protocadherin’ gene can result in reduced hearing and vision.
Usher 1F Collaborative is thrilled to announce our selection as a recipient of a Chan Zuckerberg Initiative Rare As One Project grant. This grant will enable us to grow and ensure our sustainability moving forward so that we can continue to fund vital research until we are assured that everyone with Usher 1F can continue to see the future. We are excited to be part of the Rare As One Project team!
RI USH SIG – Special Interest Group for Usher Syndrome at Retina International: Update on events & resource file on USH subtypes, genetic testing & USH genes
Dorie's mother, Laurie Shapiro, talks about her journey as an Usher 1F parent.
Dorie Shapiro talks about living and coping with Usher 1F. Read her story.
Jaime Recht, who has Usher 1F, ran both the Berlin and New York marathons and raised $2000 for Usher 1F research with both races. Read about Jaime's experiences in Berlin and New York.
Little Ebba's story as told by her parents, who are desperate to save her from a life of fading vision
David Corey and his colleagues at Harvard Medical School are trying to develop gene therapy methods to treat the deafness and blindness of Usher 1F.
In 2013, after learning that the lack of an animal model was hindering research for a cure for Usher 1F, Usher 1F Collaborative was founded. Fast forward six years. We now have our two animal models, a zebrafish and a mouse. We just held our second Usher 1F researchers meeting in Vancouver, Canada. The room was an exciting sight, filled with nine researchers, two pharmaceutical company representatives, and seven parents. Seven researchers updated us on their work toward multiple paths to an effective treatment. Now that we have our animal models, the presentations focused on treatments in development and on collaborations to test these treatments on our animal models. We have done the background work, and now we are ready for the exciting part.
Read more about our progress and plans.
Our second Usher 1F researchers meeting was an exciting event. On May 2, 2019, nine researchers, two pharmaceutical company representatives, and seven parents gathered to hear updates on research for a cure for the vision loss of Usher 1F. Read about the highlights of our meeting.
Toward a therapy for deafness and blindness in Usher syndrome
Two HMS neurobiologists studying the origins of deafness—Corey and Artur Indzhykulian, HMS assistant professor of otolaryngology at Massachusetts Eye and Ear—are joining forces with Botond Roska, an expert on retinal biology and eye disease at the Institute of Molecular and Clinical Ophthalmology in Basel, Switzerland, to develop treatments for a form of Usher syndrome.
Corey and Indzhykulian’s work will focus on a particularly severe form of the disease, known as Usher syndrome type IF.
When we began Usher 1F Collaborative in December 2013, we had $2000 in the bank and one researcher who had Usher 1F as a future initiative. Our initial goal was the development of an animal model on which to test potential new treatments. Five years later, we now have two animal models a zebrafish and a mouse, both of which share all three human Usher 1F traits, deafness, poor balance, and progressive vision loss, and six research groups actively working on a cure.
David Corey, PhD., is the Bertarelli Professor of Translational Medical Science, Department of Neurobiology, Harvard Medical School. He has previously studied the Usher 1F gene and has now taken on developing gene therapy for the vision loss of Usher 1F.
“Every great dream begins with a dreamer. Always remember, you have within you the strength, the patience, and the passion to reach for the stars to change the world.” ~Harriet Tubman We have succeeded, in […]
David R. Cox Scholarship for Rare Compassion This is a terrific opportunity to educate up and coming physicians about Usher 1F and to interest more researchers in helping us find a cure. If you have […]
By Livia Carvalho, Ph.D. The road towards testing gene therapy treatment strategies for Usher 1F has recently been joined by a new collaborative effort between research labs in the US and Australia. The labs of […]
During 2017, we doubled our number of funded research labs, adding two new researchers, Zubair Ahmed, Ph.D., at the University of Maryland, and Livia Carvalho, Ph.D., at the University of Western Australia. Drs. Ahmed and […]
By Zubair Ahmed, Ph.D. Zubair Ahmed, Ph.D., has been researching Usher 1F for many years. He was a post doctoral student and part of the team at the NIH that, in 2002, discovered the most […]
This fall, 400 riders in 13 spin studios around the United States cycled for a cure for Usher 1F. Spearheaded by Jared Root, father to Zachary who has Usher 1F, and his two friends and […]
Dorie Shapiro has Usher 1F, and her family is working to help find a cure. Please join the Shapiro family for the second annual Touchdown for Sight on December 17, 2017, beginning at 11 AM. […]
The following article appeared in Rye Brook’s Hamlet Hub. Click here to see the original story. One of the best things about being an editor is the ability to share knowledge and educate the public […]
Rachel Chaikof and Usher 1F Collaborative are featured in Moment Magazine’s September/October 2017 issue: The Road to Discovery
In the summer of 2012, at an Usher Syndrome Coalition conference, the Chief Research Officer of Foundation Fighting Blindness, Dr. Stephen Rose, spoke, providing an update on the latest Usher Syndrome research. He mentioned progress […]